BRTX
Price
$1.44
Change
-$0.12 (-7.74%)
Updated
Dec 18, 04:59 PM (EDT)
70 days until earnings call
CYYNF
Price
$0.19
Change
+$0.08 (+72.73%)
Updated
Jun 13 closing price
Ad is loading...

BRTX vs CYYNF

Header iconBRTX vs CYYNF Comparison
Open Charts BRTX vs CYYNFBanner chart's image
BioRestorative Therapies
Price$1.44
Change-$0.12 (-7.74%)
Volume$1.51K
CapitalizationN/A
Cynata Therapeutics
Price$0.19
Change+$0.08 (+72.73%)
Volume$200
CapitalizationN/A
BRTX vs CYYNF Comparison Chart
Loading...
BRTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BRTX vs. CYYNF commentary
Dec 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BRTX is a Hold and CYYNF is a Buy.

COMPARISON
Comparison
Dec 19, 2024
Stock price -- (BRTX: $1.55 vs. CYYNF: $0.19)
Brand notoriety: BRTX and CYYNF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BRTX: 78% vs. CYYNF: 100%
Market capitalization -- BRTX: $10.73M vs. CYYNF: $25.85M
BRTX [@Biotechnology] is valued at $10.73M. CYYNF’s [@Biotechnology] market capitalization is $25.85M. The market cap for tickers in the [@Biotechnology] industry ranges from $486.73B to $0. The average market capitalization across the [@Biotechnology] industry is $2.67B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BRTX’s FA Score shows that 1 FA rating(s) are green whileCYYNF’s FA Score has 0 green FA rating(s).

  • BRTX’s FA Score: 1 green, 4 red.
  • CYYNF’s FA Score: 0 green, 5 red.
According to our system of comparison, both BRTX and CYYNF are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BRTX’s TA Score shows that 4 TA indicator(s) are bullish.

  • BRTX’s TA Score: 4 bullish, 4 bearish.

Price Growth

BRTX (@Biotechnology) experienced а +5.44% price change this week, while CYYNF (@Biotechnology) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -6.67%. For the same industry, the average monthly price growth was -1.92%, and the average quarterly price growth was +0.65%.

Reported Earning Dates

BRTX is expected to report earnings on Feb 26, 2025.

Industries' Descriptions

@Biotechnology (-6.67% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CYYNF($25M) has a higher market cap than BRTX($9.76M). CYYNF YTD gains are higher at: 163.889 vs. BRTX (-10.914).
BRTXCYYNFBRTX / CYYNF
Capitalization9.76M25M39%
EBITDA-11.9MN/A-
Gain YTD-10.914163.889-7%
P/E RatioN/AN/A-
Revenue377KN/A-
Total Cash13.1MN/A-
Total Debt42.4KN/A-
FUNDAMENTALS RATINGS
BRTX vs CYYNF: Fundamental Ratings
BRTX
CYYNF
OUTLOOK RATING
1..100
5025
VALUATION
overvalued / fair valued / undervalued
1..100
28
Undervalued
60
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9897
PRICE GROWTH RATING
1..100
6340
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

BRTX's Valuation (28) in the null industry is in the same range as CYYNF (60). This means that BRTX’s stock grew similarly to CYYNF’s over the last 12 months.

BRTX's Profit vs Risk Rating (100) in the null industry is in the same range as CYYNF (100). This means that BRTX’s stock grew similarly to CYYNF’s over the last 12 months.

CYYNF's SMR Rating (97) in the null industry is in the same range as BRTX (98). This means that CYYNF’s stock grew similarly to BRTX’s over the last 12 months.

CYYNF's Price Growth Rating (40) in the null industry is in the same range as BRTX (63). This means that CYYNF’s stock grew similarly to BRTX’s over the last 12 months.

CYYNF's P/E Growth Rating (100) in the null industry is in the same range as BRTX (100). This means that CYYNF’s stock grew similarly to BRTX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BRTXCYYNF
RSI
ODDS (%)
Bullish Trend 2 days ago
83%
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
Momentum
ODDS (%)
Bullish Trend 2 days ago
86%
N/A
MACD
ODDS (%)
Bullish Trend 2 days ago
85%
N/A
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
21%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
19%
Advances
ODDS (%)
Bullish Trend 2 days ago
87%
N/A
Declines
ODDS (%)
Bearish Trend 8 days ago
90%
N/A
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
Aroon
ODDS (%)
N/A
N/A
View a ticker or compare two or three
Ad is loading...
BRTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PRTA14.041.43
+11.34%
Prothena Corp
UXIN4.280.16
+3.88%
Uxin Limited
GLSI13.010.11
+0.85%
Greenwich LifeSciences
MAA156.07-2.48
-1.56%
Mid-America Apartment Communities
AX77.11-2.09
-2.64%
Axos Financial

BRTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, BRTX has been loosely correlated with TCRT. These tickers have moved in lockstep 33% of the time. This A.I.-generated data suggests there is some statistical probability that if BRTX jumps, then TCRT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BRTX
1D Price
Change %
BRTX100%
+6.16%
TCRT - BRTX
33%
Loosely correlated
+26.22%
ETNB - BRTX
33%
Poorly correlated
+1.01%
CERO - BRTX
29%
Poorly correlated
+19.80%
GRCE - BRTX
28%
Poorly correlated
+6.59%
CYYNF - BRTX
26%
Poorly correlated
N/A
More

CYYNF and

Correlation & Price change

A.I.dvisor indicates that over the last year, CYYNF has been loosely correlated with CADL. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if CYYNF jumps, then CADL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CYYNF
1D Price
Change %
CYYNF100%
N/A
CADL - CYYNF
46%
Loosely correlated
+7.23%
URGN - CYYNF
38%
Loosely correlated
+0.27%
MLLCF - CYYNF
31%
Poorly correlated
N/A
INKT - CYYNF
27%
Poorly correlated
-7.12%
BRTX - CYYNF
26%
Poorly correlated
+6.16%
More